title: [Cognitive dysfunction in elderly patients: diagnosis and treatment].
abstract: Current clinical picture, diagnosis and treatment of cognitive disturbances in elderly patients are reviewed with a main focus on moderate cognitive impairment (MCI). The results of correction of such disturbances by pronoran according to the "Prometei" program are considered. One hundred and thirty-two physicians from 33 cities who treated 3210 patients took part in the study. Pronoran was administered to 574 patients aged over 60 years. Their health was assessed using the MMSE scale and clock-drawing test. Pronoran was used in the dosage of 50 mg daily during 12 weeks in monotherapy and in combination with vascular and metabolic drugs in combined therapy. The physicians reported improvement of cognitive functions in 82% of cases, patients--in 78%. No differences were found in efficacy of mono- and combined therapy.
authors.forename: I S
authors.initials: IS
authors.lastname: Preobrazhenskaia
authors.forename: N N
authors.initials: NN
authors.lastname: Iakhno
mesh_terms: D000367:Age Factors; D000368:Aged; D003071:Cognition / Q000187:drug effects / Q000502:physiology; D003072:Cognition Disorders / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D018697:Nootropic Agents / Q000627:therapeutic use*; D011379:Prognosis
chemical_list: D018697:Nootropic Agents